Literature DB >> 9817702

Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease.

B E Lams1, A R Sousa, P J Rees, T H Lee.   

Abstract

The airflow obstruction in chronic obstructive pulmonary disease (COPD) occurs mainly at the level of the small airways. In order to investigate the effect of smoking on small-airway submucosal immunopathology, we used immunohistochemistry in peripheral lung sections obtained at surgery from a group of smokers (n = 22) and from a group of nonsmokers (n = 22) that contained both ex-smokers (n = 17) and lifelong nonsmokers (n = 5). Subjects were also divided into those with (n = 19) and those without (n = 20) airflow obstruction. We found an increase in total eosinophils (p = 0.001) and activated eosinophils (p = 0.010), an increase in the CD8(+)/CD3(+) cell ratio (p = 0.003), and a decrease in the CD4(+)/CD8(+) cell ratio (p = 0.005) among cells infiltrating the small-airway submucosa in an area 50 micrometers deep to the basement membrane in smokers as compared with nonsmokers. There was also an increase in neutrophils (p = 0.019) when smokers were compared with lifelong nonsmokers. Neutrophil numbers correlated with numbers of eosinophils (p = 0.0003, r = 0.58). Furthermore, the CD8(+)/CD3(+) cell ratio was related to pack-years smoked (p = 0.016, r = 0.36), months since smoking cessation (p = 0.003, r = 0.47), and number of infiltrating eosinophils (p = 0.007, r = 0.43) and neutrophils (p = 0.004, r = 0.44). These findings suggest that smoking induces movement of an inflammatory infiltrate into the submucosa of the small airway, the location of the increased resistance to airflow in COPD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817702     DOI: 10.1164/ajrccm.158.5.9802121

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  21 in total

1.  Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes.

Authors:  M Laan; I Qvarfordt; G C Riise; B A Andersson; S Larsson; A Lindén
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+).

Authors:  M J Leckie; G R Jenkins; J Khan; S J Smith; C Walker; P J Barnes; T T Hansel
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

3.  Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.

Authors:  K Amin; A Ekberg-Jansson; C-G Löfdahl; P Venge
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

4.  Neutrophilic infiltration within the airway smooth muscle in patients with COPD.

Authors:  S Baraldo; G Turato; C Badin; E Bazzan; B Beghé; R Zuin; F Calabrese; G Casoni; P Maestrelli; A Papi; L M Fabbri; M Saetta
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

Review 5.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

6.  Differential distribution of inflammatory cells in large and small airways in smokers.

Authors:  Salvatore Battaglia; Thais Mauad; Annemarie M van Schadewijk; Antonia M Vignola; Klaus F Rabe; Vincenzo Bellia; Peter J Sterk; Pieter S Hiemstra
Journal:  J Clin Pathol       Date:  2006-08-17       Impact factor: 3.411

Review 7.  Eosinophilic bronchitis: clinical manifestations and implications for treatment.

Authors:  P G Gibson; M Fujimura; A Niimi
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

Review 8.  Inflammatory cells in the airways in COPD.

Authors:  R O'Donnell; D Breen; S Wilson; R Djukanovic
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

9.  Relation between duration of smoking cessation and bronchial inflammation in COPD.

Authors:  T S Lapperre; D S Postma; M M E Gosman; J B Snoeck-Stroband; N H T ten Hacken; P S Hiemstra; W Timens; P J Sterk; T Mauad
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

Review 10.  Targeted treatment in COPD: a multi-system approach for a multi-system disease.

Authors:  David Anderson; William Macnee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.